NCT02078648 2025-02-03Safety and Efficacy Study of SL-701, a Glioma-Associated Antigen Vaccine To Treat Recurrent Glioblastoma MultiformeStemline Therapeutics, Inc.Phase 1/2 Completed74 enrolled 19 charts
NCT02149225 2018-08-07GAPVAC Phase I Trial in Newly Diagnosed Glioblastoma PatientsImmatics Biotechnologies GmbHPhase 1 Completed16 enrolled